The correlation between erectile function and patient satisfaction.
The correlation between erectile function and patient satisfaction.
复制标题
勃起功能与患者满意度之间的相关性。
DOI：
10.1111/j.1743-6109.2005.00164.x
复制
发表时间：
2007
期刊：
影响因子：
--
通讯作者：
J. Mulhall
中科院分区：
文献类型：
--
作者：
P. Teloken;R. Valenzuela;M. Parker;J. Mulhall
简介
国际勃起功能指数 (IIEF) 已成为药物试验和临床研究中评估性功能的黄金标准清单。勃起功能域 (EFD) 评分正常化，即治疗结束时评分达到 26 分或更高，是目前药物试验中常规使用的终点。根据我们的经验，一些性药物得分低于 26 分的男性对自己的性功能感到满意。我们进行这项研究是为了确定 EFD 评分 <26 的男性对其治疗反应感到满意的比例。
方法
连续 100 名曾到性健康诊所就诊且至少使用过枸橼酸西地那非 4 次的患者完成了与其西地那非反应相关的 IIEF。他们还被问及有关性交能力（Q1）、对勃起药物的满意度（Q2）、药物改善勃起僵硬的能力（Q3）以及药物改善性交能力的能力（Q4）的问题。根据治疗 IIEF 评分，将患者分为 4 组（≥26、22-25、18-21 和 11-17）。将 IIEF 分数与全球评估问题的回答进行比较。
主要成果指标
患者平均年龄为 58 +/- 22 岁。对于 Q1 和 Q2，对于每个子类别，男性回答肯定、有所回答或根本不回答的百分比存在显着差异。在 EFD 分数为 22-25 的组中，67% 至少在一定程度上同意 Q1，66% 同意 Q2。在该组中，分别有 84% 和 78% 的人对第三季度和第四季度的回答是肯定的。没有 EFD 评分 <22 的患者明确同意 Q1 或 Q2。
结论
这些数据表明，相当一部分 EFD 评分为 21-25 的患者可以拥有令人满意的性关系，并且他们对勃起药物感到满意。
INTRODUCTION
The International Index of Erectile Function (IIEF) has become the gold standard inventory for the assessment of sexual function in drug trials and in clinical research. Normalization of the erectile function domain (EFD) score, an end of treatment score of 26 or higher, is an end-point that is currently being used routinely in drug trials. It has been our experience that some men with scores less that 26 on a sexual pharmaceutical are content with their sexual function. We undertook this study to define what proportion of men with EFD scores <26 are satisfied with their therapeutic response.
METHODS
100 consecutive patients who had presented to a sexual health clinic and who had used sildenafil citrate on at least 4 occasions completed the IIEF pertaining to their sildenafil response. They were also asked questions, pertaining to their ability to have sexual intercourse (Q1), their satisfaction with their erectogenic medication (Q2), the ability of the medication to improve erectile rigidity (Q3), and the ability of the medication to improve their ability to have sexual intercourse (Q4). Patients were subcategorized into 4 groups based on treatment IIEF scores (>/=26, 22-25, 18-21, and 11-17). The IIEF scores were compared to the responses to the global assessment questions.
MAIN OUTCOME MEASURES
The mean patient age was 58 +/- 22 years. For Q1 and Q2, for each subcategory, there was a significant difference in the percentage of men answering definitely, somewhat, or not at all. In the group with EFD scores 22-25, 67% agreed at least somewhat with Q1 and 66% with Q2. In this group 84% and 78% responded in the affirmative to Q3 and Q4, respectively. No patient with an EFD score <22 definitely agreed with Q1 or Q2.
CONCLUSIONS
These data indicate that a significant proportion of patients with EFD scores 21-25 can have sexual relations that are satisfactory and that they are satisfied with their erectogenic medication.
影响因子：
120.7
作者：
Laumann, EO;Paik, A;Rosen, RC
通讯作者：
Rosen, RC